Is there a role for immune and anti-inflammatory therapy in type 2 diabetes?

被引:0
作者
Sathyapalan, T. [1 ]
Atkin, S. L. [1 ]
机构
[1] Hull York Med Sch, Unit Endocrinol & Metab, Kingston Upon Hull, N Humberside, England
关键词
Inflammation; Diabetes mellitus; type; 2; Cytokines; Adipokines; C-REACTIVE PROTEIN; ENDOPLASMIC-RETICULUM STRESS; IL-1 RECEPTOR ANTAGONIST; BETA-CELL DYSFUNCTION; NECROSIS-FACTOR-ALPHA; MONOCYTE CHEMOATTRACTANT PROTEIN-1; ACTIVATED SIGNALING PATHWAYS; INDUCED INSULIN-RESISTANCE; NF-KAPPA-B; RHEUMATOID-ARTHRITIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is a growing body of evidence to suggest that type 2 diabetes is associated with a generalised activation of the innate immune system, in which there is a chronic low-grade inflammation. Further evidence for roles of inflammation in type 2 diabetes comes from clinical studies using either anti-inflammatory approaches or biological agents that target specific proinflammatory cytokine pathways to improve parameters of glucose control especially with IL-1 beta (Interleukin 1 beta) antagonism and salsalate (non-acetylated prodrug of salicylate) treatment. In this review, recent evidence implicating the pathological involvement of the immune system in type 2 diabetes is examined, together with the role of potential treatment modalities targeting the immune system in the management of type 2 diabetes.
引用
收藏
页码:147 / 156
页数:10
相关论文
共 92 条
[1]   Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].
Albert, MA ;
Danielson, E ;
Rifai, N ;
Ridker, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70
[2]   Endoplasmic reticulum stress and diabetes mellitus [J].
Araki, E ;
Oyadomari, S ;
Mori, M .
INTERNAL MEDICINE, 2003, 42 (01) :7-14
[3]   IKK-β links inflammation to obesity-induced insulin resistance [J].
Arkan, MC ;
Hevener, AL ;
Greten, FR ;
Maeda, S ;
Li, ZW ;
Long, JM ;
Wynshaw-Boris, A ;
Poli, G ;
Olefsky, J ;
Karin, M .
NATURE MEDICINE, 2005, 11 (02) :191-198
[4]   Comparison of Simvastatin and Metformin in Treatment of Polycystic Ovary Syndrome: Prospective Randomized Trial [J].
Banaszewska, Beata ;
Pawelczyk, Leszek ;
Spaczynski, Robert Z. ;
Duleba, Antoni J. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (12) :4938-4945
[5]   CYTOTOXICITY OF HUMAN PI-7 INTERLEUKIN-1 FOR PANCREATIC-ISLETS OF LANGERHANS [J].
BENDTZEN, K ;
MANDRUPPOULSEN, T ;
NERUP, J ;
NIELSEN, JH ;
DINARELLO, CA ;
SVENSON, M .
SCIENCE, 1986, 232 (4757) :1545-1547
[6]   Free Fatty Acids Induce a Proinflammatory Response in Islets via the Abundantly Expressed Interleukin-1 Receptor I [J].
Boeni-Schnetzler, Marianne ;
Boller, Simone ;
Debray, Sarah ;
Bouzakri, Karim ;
Meier, Daniel T. ;
Prazak, Richard ;
Kerr-Conte, Julie ;
Pattou, Francois ;
Ehses, Jan A. ;
Schuit, Frans C. ;
Donath, Marc Y. .
ENDOCRINOLOGY, 2009, 150 (12) :5218-5229
[7]   Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): Implication of macrophages resident in the AT [J].
Bruun, JM ;
Lihn, AS ;
Pedersen, SB ;
Richelsen, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :2282-2289
[8]   Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB [J].
Cai, DS ;
Yuan, MS ;
Frantz, DF ;
Melendez, PA ;
Hansen, L ;
Lee, J ;
Shoelson, SE .
NATURE MEDICINE, 2005, 11 (02) :183-190
[9]   Accelerated Increase in Serum Interleukin-1 Receptor Antagonist Starts 6 Years Before Diagnosis of Type 2 Diabetes Whitehall II Prospective Cohort Study [J].
Carstensen, Maren ;
Herder, Christian ;
Kivimaeki, Mika ;
Jokela, Markus ;
Roden, Michael ;
Shipley, Martin J. ;
Witte, Daniel R. ;
Brunner, Eric J. ;
Tabak, Adam G. .
DIABETES, 2010, 59 (05) :1222-1227
[10]   Metformin reduces C-reactive protein but not complement factor C3 in overweight patients with Type 2 diabetes mellitus [J].
Carter, AM ;
Bennett, CE ;
Bostock, JA ;
Grant, PJ .
DIABETIC MEDICINE, 2005, 22 (09) :1282-1284